Department of Diabetes, Endocrinology and Nutrition, Hospital of Girona 'Dr Josep Trueta'Institut d'Investigació Biomèdica de Girona (IdIBGi), CIBEROBN (CB06/03/010) and Instituto de Salud Carlos III (ISCIII), Girona, Spain.
Grup de Química Bioinspirada, Supramolecular i Catàlisi (QBIS-CAT), Institut de Química Computacional i Catàlisi (IQCC), Departament de Química, Universitat de Girona, C/M. Aurèlia Capmany 69, 17003, Girona, Catalonia, Spain.
Food Chem Toxicol. 2019 Sep;131:110543. doi: 10.1016/j.fct.2019.05.051. Epub 2019 May 30.
A dual role of hydrogen sulfide (HS) in inflammation is well-reported and recent studies demonstrated adipogenic effects of HS in 3T3-L1 cells. Here, we aimed to investigate the effects of HS on adipocyte differentiation and inflammation. HS concentration in 3T3-L1 culture media was increased during adipocyte differentiation in parallel to adipogenic and Cth gene expression, and its inhibition using DL-Propargyl Glycine (PPG) impaired 3T3-L1 differentiation. GYY4137 and NaS administration only in the first or in the last stage of adipocyte differentiation resulted in a significant increased expression of adipogenic genes. However, when GYY4137 or NaS were administrated during all process no significant effects on adipogenic gene expression were found, suggesting that excessive HS administration might exert negative effects on adipogenesis. In fact, continuous addition of NaS, which resulted in NaS excess, inhibited adipogenesis, whereas time-expired NaS had no effect. In inflammatory conditions, GYY4137, but not NaS, administration attenuated the negative effects of inflammation on adipogenesis and insulin signaling-related gene expression during adipocyte differentiation. In inflamed adipocytes, NaS administration enhanced the negative effects of inflammatory process. Altogether these data showed that slow-releasing HS improved adipocyte differentiation in inflammatory conditions, and that HS proadipogenic effects depend on dose, donor and exposure time.
硫化氢 (HS) 在炎症中的双重作用已有报道,最近的研究表明 HS 在 3T3-L1 细胞中具有成脂作用。在这里,我们旨在研究 HS 对脂肪细胞分化和炎症的影响。在脂肪细胞分化过程中,3T3-L1 培养基中的 HS 浓度与成脂基因和 Cth 基因的表达平行增加,并用 DL-Propargyl Glycine (PPG) 抑制 HS 会损害 3T3-L1 分化。仅在脂肪细胞分化的第一阶段或最后阶段给予 GYY4137 和 NaS,会导致脂肪生成基因的表达显著增加。然而,当 GYY4137 或 NaS 在整个过程中给予时,对脂肪生成基因表达没有显著影响,表明过量的 HS 给药可能对脂肪生成产生负面影响。事实上,持续添加 NaS 导致 NaS 过量会抑制脂肪生成,而过期的 NaS 则没有影响。在炎症条件下,GYY4137 给药而非 NaS 给药可减轻炎症对脂肪生成和胰岛素信号相关基因表达的负面影响。在炎症脂肪细胞中,NaS 给药增强了炎症过程的负面影响。总之,这些数据表明,缓慢释放的 HS 可改善炎症条件下的脂肪细胞分化,并且 HS 的促脂肪生成作用取决于剂量、供体和暴露时间。